HIGH QUALITY SCIENTIFIC CONTENT,  ONLINE OPEN ACCESS,  GLOBAL SCIENTIFIC AUDIENCE,  COST EFFECTIVE, ANY ONE CAN DOWNLOAD REPRINTS 
Spreading knowledge

Google Scholar

Google Scholar

Archives

Back 

CRAMS: MOVING UP THE VALUE CHAIN. Virender Kumar, Pradeep Kumar, Tarun Gugnani, Mamta Seth1

CRAMS: MOVING UP THE VALUE CHAIN

Virender Kumar, Pradeep Kumar, Tarun Gugnani, Mamta Seth1

International Journal of Natural Product Science 2012: Spl Issue 1:51.

Abstract(RBIP-51)

Pharmaceutical industries in India have made phenomenal progress in the past few years and are considered as a reliable source of quality medicines at affordable prices. It is also emerging as a destination of choice for the Contract Research and Manufacturing Services (CRAMS). CRAMS in health care has been successful in India. This activity is likely to increase due to the diminishing new product pipeline as well as a host of molecules which are going off the patent leading to erosion in the sales volume and profit. This is the opportunity for the vast pool of technocrats venturing as entrepreneurs. CRAMS is a safe and rewarding model for the companies provided they adhere to strict quality measures. With the increasing cost, pressure and speed, pharma companies prefer CRAMS as it has advantages like lower cost, excellent research facilities, process development, scale up talent pool and IT infrastructures. It is a major area for outsourcing. The association of companies in CRAMS can be explained by the Hub and Spoke Model. It is expected that soon more international companies will like to give their discovery projects to India. The trend thus has changed from a pure play drugs manufacturer and marketer to end-to-end R&D solution providers.
Attachments:
Time to create page: 0.13 seconds


Copyright © All rights reserved Science Instinct Publications sciipub.com